524731 — Jenburkt Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousSmall CapHigh Flyer

Annual balance sheet for Jenburkt Pharmaceuticals, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	R2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	IAS	IAS	IAS	IAS	—
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	561	466	495	740	250
Net Total Accounts Receivable
Net Total Receivables	146	179	215	252	209
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	800	759	811	1,097	565
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	104	113	112	112	547
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	1,212	1,429	1,418	1,651	1,962
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	180	213	158	164	188
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Funded Status
Total Liabilities	227	256	194	202	244
Common Stock
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	985	1,174	1,224	1,449	1,718
Total Liabilities & Shareholders' Equity	1,212	1,429	1,418	1,651	1,962
Total Common Shares Outstanding